Clinical Trials · NCT03174353

A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula

Name: A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Lanreotide

Phase: Phase 2
Recruitment status: Completed
Sponsor: University of Washington
Enrollment: 114
Start date: Feb 2018
Locations: 1 site, United States
Primary endpoint: Combined Clinically Significant Postoperative Pancreatic Fistula and Intra-abdominal Abscess

View Lanreotide compound reference